As of November this year, based on ICU Medical's most recent financial report, the company's trailing twelve months EPS is $2.41. During 2025, ICUI reported a per-share earnings of $0.03, which shows a rise compared to the EPS of -$4.83 recorded in 2024. ICU Medical's EPS for the quarterly period ending on Sep 30, 2026 came in at $1.07.
The yearly earnings per share during 2025 was $0.03, a rise of 100.6% compared to -$4.83 recorded in 2024. Over the quarter ending Sep 30, 2026, the earnings per share came in at $1.07, reflecting a 864.3% increase compared to the same quarter a year earlier. As of September 2026, the TTM EPS is $2.41. During 2024, the annual earnings per share was -$4.83, representing a decrease of 292.7% compared to 2023.
ICU Medical has recorded a growth in earnings per share of 864.3% over the past 12 months (YoY, quarterly). ICU Medical had an average annual EPS growth of -62.7% in the last five years. When assessed over a ten-year period, ICUI's average EPS annual growth was -36.6%.
| Stock name | Price to Earnings | EPS grwoth 1Y | EPS grwoth 3Y | EPS grwoth 5Y |
|---|---|---|---|---|
| TFX Teleflex Incorporated | 18.48 | -1,462.4% | N/A | N/A |
| PODD Insulet Corporation | 24.4 | -41.2% | 268.8% | 99.9% |
| MMSI Merit Medical Systems Inc | 32.23 | 4.8% | 18.3% | N/A |
| EW Edwards Lifesciences Corp | 59.6 | -73.6% | -9.2% | 6.9% |
| BDX Becton Dickinson & Company | 64.98 | -0.9% | -0.6% | 16.2% |
| ICUI ICU Medical Inc | 73.63 | 100.6% | N/A | -62.7% |
| DCTH Delcath Systems Inc | 119.11 | 108.6% | N/A | N/A |
| ANGO Angiodynamics Inc | N/A | -6% | N/A | N/A |
| BAX Baxter International Inc | N/A | -47.2% | N/A | N/A |
All data is based on quarterly TTM periods, unless otherwise specified.